🚀 Arrenca el nou projecte de IHI: #LIGAND-AI, liderat per @thesgc.bsky.social i Pfizer, per transformar el desenvolupament de fàrmacs mitjançant la IA
Albert Antolín, incorporat recentment al VHIO, colidera l’àrea de machine learning amb IBM
➡️ https://linke.to/LIGANDAI_Cat
#Target2035 #HorizonEurope

🚀 Arranca el nuevo proyecto de IHI: #LIGAND-AI, liderado por @thesgc.bsky.social y Pfizer, para transformar el
desarrollo de fármacos a través de la #IA
Albert Antolín, incorporado recientemente al VHIO, colidera el área de machine learning con IBM.
➡️ https://linke.to/LIGANDAI_Cast
#Target2035

New IHI project launches: #LIGAND-AI, led by @thesgc.bsky.social & Pfizer to build open datasets of protein–ligand interactions and train AI models for #DrugDiscovery
Albert Antolín, who recently joined VHIO, co-leads the machine learning work with IBM.

➡️ https://linke.to/LIGANDAI_Eng
#Target2035

The Chemical Probes Portal turns ten. Use it! Last week we highlighted a new tool to computationally predict whether a molecule might aggregate, thereby causing false positives. This do...

🎉 The Chemical Probes Portal turns 10!
We’re honoured to be featured in Dr Dan Erlanson’s latest Practical Fragments blog, reflecting on a decade of advancing chemical biology and open science.

🔗 Read the blog: practicalfragments.blogspot.com/2025/08/the-...
#ChemicalProbes #Target2035

Protein–ligand data at scale to support machine learning - Nature Reviews Chemistry Target 2035 aims to develop a potent and selective pharmacological modulator for every human protein by 2035 with the results made publicly available. This Roadmap article sets out how that will be ac...

UCL, with @thesgc.bsky.social and scientists from 30 leading organisations, has published a landmark roadmap in @natrevchem.nature.com‬, outlining a global, open science strategy to scale up hit discovery efforts for every human protein. #Target2035 #DrugDiscovery
www.nature.com/articles/s41...

Have you caught Episode 6 of the #Target2035 Podcast? 🎙️
Danette Daniels (@ FoghornTx) joins Milka Kostic, to dive into the power of #ProteinDegradation – what sets degraders apart, why #TPD is surging, and how we speed discovery.

Plus: championing #WomenInSTEM 💪

🎙️ New podcast episode alert! Professor Paul Workman joins Opher Gileadi on the #Target2035 podcast to dive into the science of chemical probes. 🧪

🔍 What makes a great probe?
🛑 Common lab mistakes.
🌐 Learn about the Chemical Probes Portal.

🎧 Listen now 👇

Robots queuing up to fail Claims of an AI revolution in drug discovery are missing the biggest problem

Designing compounds with robots and AI will not accelerate drug discovery says @dereklowe.bsky.social (agreed). But designing great #ChemicalProbes using AI (eventually) and putting them in the hands of biologists just might. #Target2035

www.chemistryworld.com/opinion/robo...

🚨 Just Launched! Episode 1 of the Target 2035 Podcast Series 🎧
Join @LabScribbles as they chat with @CherylArrowsmi1, a trailblazer in chemical biology and co-founder of #Target2035. Discover the story behind this ambitious initiative for #OpenScience and #DrugDiscovery.
🎙️ Listen now: Link below 👇

The #Target2035 mission is to discover chemical tools for all human proteins by 2035. An ambitious and impactful mission!

Chemical coverage of human biological pathways - Reactome Pathway Database Reactome is pathway database which provides intuitive bioinformatics tools for the visualisation, interpretation and analysis of pathway knowledge.

An exciting #ReactomeResearchSpotlight!
In the feature article of the October 2024 issue of Drug Discovery Today titled "Chemical coverage of human biological pathways" by Kwak et al. describe the #Target2035 initiative!
Read more: reactome.org/content/reac...